MARATTO

article · Tropical Plant Research

A mini-review on the pharmacognosy and phytochemistry of a tropical medicinal plant: Annona senegalensis Pers. (Annonaceae)

201714 citationsOpen accessUniversité de Kinshasa (UNIKIN)

Abstract

The aim of this mini-review was to collect data obtained from various studies carried out by different authors concerning the phytochemistry and pharmacognosy of Annona senegalensis (Annonaceae). This review has been compiled using references from major databases such as PubMed, PubMed Central, Science Direct and Google scholars. An extensive survey of literature revealed that A. senegalensis is a good source of health promoting secondary metabolites such as terpenoic acids (kaurenoic acid) among others that could have many wonderful applications (like antisickling properties).Traditionally, the plant is used as stimulant, pain reliever etc. whereas the plant possess beneficial effects such as anti-oxidant, antimicrobial, Antidiarrheal, anti-inflamatory, anti-parasitic, anticonvulsant, antimalarial, anti-trypanosomal, antisnake venom and Antinociceptive and many other medicinal properties. The results of the present review of literature makes A. senegalensis an interesting candidate for advanced anti-sickle cell anemia investigations such as erythroid differentiation and fetal hemoglobin induction effects of this plant using K562 cell lines as model system.

Research topics

  • Traditional and Medicinal Uses of Annonaceae
  • Ethnobotanical and Medicinal Plants Studies
  • Phytochemistry and biological activities of Ficus species

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.22271/tpr.2017.v4.i1.024

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.